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A b s t r A c t
Out of hospital cardiac arrest remains a major cause of mortality and morbidity de-
spite progress in resuscitative practices. The number of survivors with severe neuro-
logical impairment at hospital discharge is similarly dismal. Recently, much attention 
has been directed toward the use of mild therapeutic hypothermia in postresuscitation 
care of comatose survivors of cardiac arrest. Two randomized, controlled clinical tri-
als published in the New England Journal of Medicine showed that after resuscitation 
mild hypothermia lowers mortality, improves neurological outcome after successfully 
treated cardiac arrest, and is recommended by the 2005 update guidelines of Inter-
national Liaison Committee on Resuscitation and European Resuscitation Council 
(ERC). In the present article pathophysiological mechanisms of hypothermia, cooling 
methods and potential side effects are briefly discussed. Questions regarding imple-
mentation of therapeutic hypothermia recommendations in every day clinical practice 
and future investigation are also addressed.
I N t r O D U c t I O N
Out of hospital cardiac arrest (CA) affects more than 375000 individuals per year in 
Europe [1], while it carries a greater than 0% mortality rate, leading to over 300,000 
deaths in the United States each year [2]. Despite the development of pharmacologic 
therapies for CA and the improved access to electrical defibrillation, this mortality rate 
has not declined significantly over the past few decades. Cardiopulmonary resuscitation 
restores the return of spontaneous circulation (ROSC) in about 100,000 patients a 
year in the US while 60% of these die from neurological complications [3]. Among the 
few survivors to hospital discharge, neurological impairment often remains a lasting 
morbidity. Only 3-20% of resuscitated patients are able to resume their former lifestyles 
[4]. Therapeutic hypothermia has been used in surgical procedures for decades. The 
means by which hypothermia provides neuroprotection are uncertain, but preliminary 
studies suggested that mild induced hypothermia (MIH) could improve cardiological 
and neurological outcome in patients who suffered CA, while MIH side-effects could 
successfully be managed in modern intensive care units (ICU).
t H E r A P E U t I c  H Y P O t H E r m I A  A f t E r  c A r D I A c  A r r E s t
A number of landmark studies and a metanalysis, published over the past few 
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years, have demonstrated that cooling patients can provide 
significant survival benefit after initial resuscitation from 
CA [5-8]. The European HACA trial group demonstrated an 
improvement in survival to hospital discharge with favorable 
neurological status in cooled patients compared to normother-
mic patients surviving arrest (53% vs. 36%, respectively), with 
no significant adverse events from cooling [5]. In the Austral-
ian study carried out by Bernard et al there was a significant 
difference in the rate of good neurological outcome: 21 of 43 
patients (4%) in the hypothermia group vs.  of 34 patients 
(26%) in the normothermia group [6]. In a previous, limited 
size clinical trial by Hachimi-Idrissi et al improved outcome 
was reported in 2 of 16 patients randomized to hypothermia of 
34°C for a maximum of 4 hours but in none of the 14 patients 
randomized to normothermia [7] (Table 1). Several of these 
MIH investigations were well-designed randomized controlled 
trials, providing better evidence for the use of cooling than 
many pharmacologic interventions after CA [8]
On the strength of these studies, the International Liaison 
Committee on Resuscitation (ILCOR) and the American 
Heart Association/European Resuscitation Council in the 
2005 published guidelines [,10] recommend that:
Unconscious adult patients with ROSC after out-of-hospi-
tal cardiac arrest (VF) should be cooled to 32oC to 34oC 
for 12 hours (Class IIa).
Similar therapy may be beneficial for patients with non- VF 
arrest out-of or in-hospital arrest (Class IIb).
Various pathophysiological mechanisms are associated to 
brain damage during and after CA and subsequent resuscita-
tion. A temporary phase of interrupted or limited cerebral 
blood flow is followed by rapid or delayed cell reperfusion 
[11]. Neurological injury and mortality after ROSC may be 
due in part to this “ischemia-reperfusion” injury. The basic 
concept is that while the lack of blood flow (ischemia) leads to 
pathophysiological changes, uncontrolled reperfusion (return 
of blood flow after resuscitation) may amplify these injury 
-
-
processes. Hypothermia may block a number of these steps 
and lessen cellular injury by slowing cerebral metabolism in 
relation with other mechanisms. These include a reduction in 
neuronal apoptosis,
 
inhibition of chemical reactions associated 
with reperfusion injury, alterations in intracellular cation 
concentrations due to ion pump dysfunction, suppression of 
inflammatory cytokines,
 
reduction of free radical production
 
and reduction of cerebral edema [12]. It appears that cooling as 
soon as possible (within several hours of resuscitation) is best, 
although animal work suggests that cooling during resuscita-
tion might be even better, however this has not been shown 
clinically at this time [13]. There are no no studies comparing 
early versus delayed hypothermia in humans.
Numerous techniques have been described for inducing 
mild hypothermia. These embrace ice bags, blankets contain-
ing circulating coolant or cold air, a helmet or cooling cap with 
chemical cooling capacities, drugs, cold carotid artery infu-
sion, ice water nasal lavage, cold peritoneal lavage, cardiopul-
monary bypass, and endovascular cooling with a catheter [14]. 
Infusion of cold (4°C) lactated Ringer solution at 30 mL/kg 
over 30 minutes after resuscitation from out-of-hospital CA 
has been a safe and successful cooling technique [15]. This 
method has been sufficient and effective also in pre-hospital 
settings, and has also been studied in combination with en-
dovascular cooling or with ice-water cooling blankets [16]. In 
an animal study, extracorporeal venovenous cooling has been 
tested as a thriving procedure to rapidly induce therapeutic 
mild hypothermia [17].
Contraindications to MIH are cardiogenic shock, coagula-
tion disorders, pregnancy, and cardiac arrhythmias. Potential 
and frequent complications of mild to moderate hypothermia 
include coagulopathy and impaired coagulation cascade, elec-
trolyte disorders, increased diuresis, insulin resistance, and 
changes in drug effects and drug metabolism [10]. Myocardial 
ischemia, infections, and severe rebound hyperthermia may 
also occur. Therefore it is important that all patients who 
receive hypothermia should get standard ICU care such as fre-
tAbLE 1. Outcomes of mild induced therapeutic hypothermia utilization after out of hospital cardiopulmonary resus-
citation.
Hypothermia
(%)
Normothermia
(%)
rr
(%)
P value
Alive at hospital discharge with favourable neurological recovery
HACA 72/136 (53%) 50/137 (36%) 1.5 (1.14-1.8) 0.006
Bernard 21/43 (4%) /34 (26%) 1.75 (0.-2-43) 0.052
Idrissi 4/16 (25%) 1/17 (6%) 4.25 (0.70-53.83) 0.16
Alive at 6 months with favourable neurological recovery
72/136 (52%) 50/137 (36%) 1.44 (1.11-1.76) 0.00HACA
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quent turning, oral care every 2 to 4 hours, ventilator bundling 
interventions, glucose level control, peptic ulcer prophylaxis, 
and deep vein thrombosis prophylaxis [18].
Although, several registries have been founded to follow 
up the use of MIH after CA and patient outcome (HACA-
Registry, Northern Hypothermia network), guideline im-
plementation in every day practice is still poor[18]. Despite 
recent developments, it remains unclear whether physicians 
have begun to use this treatment modality. In a recent practice 
survey addressing the use of hypothermia after CA in the USA, 
87% of the responders practicing emergency medicine, critical 
care, or cardiology had not used it [1]. In a similar survey a 
year later, the percentage of non-users was 74% in the USA, 
6% in Great Britain, and 3% in Finland [20]. Reasons why 
physicians have not used hypothermia include lack of aware-
ness of supporting data, technical constraints, and the lack 
of hypothermia protocol incorporation into ALS (Advanced 
Life Support). Better understanding of the pathophysiology of 
resuscitation and the injury processes on which hypothermia 
acts will serve to further promote the use of this promising 
method to save lives.
Unresolved issues concerning the use of therapeutic hypo-
thermia in CA remain regarding patient selection (children, 
neonates), optimal timing, duration and depth of cooling, and 
methods to minimize hypothermia-related complications [21]. 
Large randomized studies addressing therapeutic hypother-
mia after out-of-hospital CA with initial rhythms other than 
VF or in-hospital cardiac arrest have not appeared thus far. 
Further research is also needed to elucidate the safety and 
effect of hypothermia in combination with thrombolysis or 
other neuroprotective methods [22].
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